$CRTG
CORETEC GROUP INC.

2021 Q1 Form 10-Q Financial Statement

#000143774921012001 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $342.5K $289.8K
YoY Change 18.17% 56.74%
% of Gross Profit
Research & Development $37.60K $43.89K
YoY Change -14.34% 118.85%
% of Gross Profit
Depreciation & Amortization $0.00 $126.00
YoY Change -100.0% -33.33%
% of Gross Profit
Operating Expenses $37.60K $43.89K
YoY Change -14.34% 118.85%
Operating Profit
YoY Change
Interest Expense $58.36K $220.4K
YoY Change -73.52% 136.09%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$438.4K -$530.3K
YoY Change -17.33% 77.77%
Income Tax
% Of Pretax Income
Net Earnings -$438.4K -$530.3K
YoY Change -17.33% 77.76%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$1.967K -$2.739K
COMMON SHARES
Basic Shares Outstanding 222.9M 202.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.228M $80.49K
YoY Change 6394.81% 114885.71%
Cash & Equivalents $5.228M $80.49K
Short-Term Investments
Other Short-Term Assets $154.8K $47.52K
YoY Change 225.78% 78.71%
Inventory
Prepaid Expenses $154.8K $47.52K
Receivables
Other Receivables
Total Short-Term Assets $5.382M $128.0K
YoY Change 4104.67% 380.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $166.0K $166.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $31.70K $3.580K
YoY Change 785.47% 54.31%
Total Long-Term Assets $1.237M $1.289M
YoY Change -4.04% -5.82%
TOTAL ASSETS
Total Short-Term Assets $5.382M $128.0K
Total Long-Term Assets $1.237M $1.289M
Total Assets $6.619M $1.417M
YoY Change 367.19% 1.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $672.3K $557.1K
YoY Change 20.67% -19.39%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $23.40K $22.37K
YoY Change 4.6% -72.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $695.6K $579.5K
YoY Change 20.05% -81.57%
LONG-TERM LIABILITIES
Long-Term Debt $1.373M $23.39K
YoY Change 5769.05%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.373M $23.39K
YoY Change 5769.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $695.6K $579.5K
Total Long-Term Liabilities $1.373M $23.39K
Total Liabilities $2.068M $602.9K
YoY Change 243.09% -80.83%
SHAREHOLDERS EQUITY
Retained Earnings -$7.651M -$6.025M
YoY Change 27.01% 52.98%
Common Stock $48.34K $40.53K
YoY Change 19.26% 195.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.551M $813.9K
YoY Change
Total Liabilities & Shareholders Equity $6.619M $1.417M
YoY Change 367.19% 1.55%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$438.4K -$530.3K
YoY Change -17.33% 77.76%
Depreciation, Depletion And Amortization $0.00 $126.00
YoY Change -100.0% -33.33%
Cash From Operating Activities -$19.22K -$324.6K
YoY Change -94.08% 329.38%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.913M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.225M 347.0K
YoY Change 1405.77% 384.09%
NET CHANGE
Cash From Operating Activities -$19.22K -324.6K
Cash From Investing Activities
Cash From Financing Activities $5.225M 347.0K
Net Change In Cash $5.205M 22.35K
YoY Change 23195.84% -668.72%
FREE CASH FLOW
Cash From Operating Activities -$19.22K -$324.6K
Capital Expenditures $0.00
Free Cash Flow -$19.22K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.0812
CY2021Q1 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1236665
CY2020Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1243972
CY2021Q1 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y200D
CY2021Q1 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
CY2021Q1 crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
88914000
CY2021Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
334651
CY2020Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
363750
CY2021Q1 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
CY2020Q1 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
310303
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2021Q1 crtg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exchanged
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExchanged
2000000
CY2021Q1 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
1200000
CY2021Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
70264
CY2021Q1 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
CY2021Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
70264
CY2020Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
CY2021Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
240
CY2020Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
672247
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
396019
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12153798
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8033313
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
310303
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
18723
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62785
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53447
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21526
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
202882
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20057
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20057
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
208651539
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39568882
CY2021Q1 us-gaap Assets
Assets
6619144
CY2020Q4 us-gaap Assets
Assets
1446154
CY2021Q1 us-gaap Assets Current
AssetsCurrent
5382479
CY2020Q4 us-gaap Assets Current
AssetsCurrent
202182
CY2021Q1 us-gaap Cash
Cash
5227674
CY2020Q4 us-gaap Cash
Cash
22219
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58149
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5227674
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80494
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5205455
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22345
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0515
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2190000
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
142604000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241687349
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213751145
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241687349
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213751145
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
48337
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
42750
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
438421
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
530307
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
31696
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18946
CY2021Q1 us-gaap Depreciation
Depreciation
CY2020Q1 us-gaap Depreciation
Depreciation
126
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.002
CY2020Q4 us-gaap Goodwill
Goodwill
166000
CY2020Q1 us-gaap Interest Expense
InterestExpense
220439
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
33603
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
18780
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
18723
CY2020Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2021Q1 us-gaap Liabilities
Liabilities
2068411
CY2020Q4 us-gaap Liabilities
Liabilities
709197
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.003
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1038969
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1059026
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
342457
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
265974
CY2021Q1 us-gaap Goodwill
Goodwill
166000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
346492
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-58693
CY2021Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
12750
CY2020Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25158
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-41303
CY2021Q1 us-gaap Interest Expense
InterestExpense
58362
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6619144
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1446154
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
695646
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
442599
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5224670
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
346977
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19215
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-324632
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-438421
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-530307
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
23399
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
46580
CY2021Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1372765
CY2020Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
266598
CY2021Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1372765
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
266598
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3780
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
8262
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
154805
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179963
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -9pt; text-indent: 8pt;"><div style="display: inline; font-style: italic;">Reclassification</div></div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&nbsp;</div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;">Certain amounts in the prior period condensed statement of operations have been reclassified to conform to the presentation of the current year. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the previously reported net loss.</div></div></div></div></div>
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4913200
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
23181
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
16773
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37601
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43894
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7651471
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2021Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
17462174
CY2021Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
18212174
CY2021Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y215D
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4913200
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4550733
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813908
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&nbsp;</div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</div></div></div></div></div>
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
222856458
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
193621826

Files In Submission

Name View Source Status
0001437749-21-012001-index-headers.html Edgar Link pending
0001437749-21-012001-index.html Edgar Link pending
0001437749-21-012001.txt Edgar Link pending
0001437749-21-012001-xbrl.zip Edgar Link pending
crtg-20210331.xml Edgar Link completed
crtg-20210331.xsd Edgar Link pending
crtg-20210331_cal.xml Edgar Link unprocessable
crtg-20210331_def.xml Edgar Link unprocessable
crtg-20210331_lab.xml Edgar Link unprocessable
crtg-20210331_pre.xml Edgar Link unprocessable
crtg20210331_10q.htm Edgar Link pending
ex_248279.htm Edgar Link pending
ex_248280.htm Edgar Link pending
ex_248281.htm Edgar Link pending
ex_248282.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending